Polyclonal Antibody to Prostaglandin F2 Receptor Negative Regulator (PTGFRN)
Code | Size | Price |
---|
PAB767Hu02-20ul | 20ul | £86.00 |
Quantity:
PAB767Hu02-100ul | 100ul | £159.00 |
Quantity:
PAB767Hu02-200ul | 200ul | £214.00 |
Quantity:
PAB767Hu02-1ml | 1ml | £490.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
CD315; CD9P-1; EWI-F; FPRP; SMAP-6; CD9 partner 1; Glu-Trp-Ile EWI motif-containing protein F; Prostaglandin F2-alpha receptor-associated protein
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen:
RPB767Hu02-Recombinant Prostaglandin F2 Receptor Negative Regulator (PTGFRN)
Item Name:
Prostaglandin F2 Receptor Negative Regulator
Source:
Polyclonal antibody preparation
Subcategory:
Polyclonal antibody preparation
USAGE:
Western blotting: 0.5-2ug/mL
Immunohistochemistry: 5-20ug/mL
Immunocytochemistry: 5-20ug/mL
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20ug/mL
Immunocytochemistry: 5-20ug/mL
Optimal working dilutions must be determined by end user.
Related Products
Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recombinant Prostaglandin F2 Receptor Negative Regulator (PTGFRN) | RPB767Hu02 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||